OverviewSuggest Edit
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, and medical sterilization industries. The Company's Human Nutrition & Health segment offers creamer systems, dairy replacers, powdered fats, cereals, and human grade choline nutrients and mineral amino acid chelated products for wellness applications. Its Animal Nutrition & Health segment provides microencapsulated products, chelation technology, and choline chloride. The Specialty Products segment offers ethylene oxide and single use canisters with ethylene oxide for sterilizing re-usable devices. It also sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as sells chelated minerals for high value crops. The Company's Industrial Products segment provides derivatives of choline chloride for use in industrial applications, and methylamines.
| Type | Public | |
| Founded | 1967 | |
| HQ | New Hampton, US | Map |
| Website | balchem.com | |
| Employee Ratings | More |
Key People/Management at Balchem
Ted Harris
Chairman and Chief Executive Officer
Martin Bengtsson
CFO
Mark Stach
General Counsel
John Televantos
Director
Paul D. Coombs
Director
Jim Hyde
Vice President and General Manager of Human Nutrition & Health
Balchem Office Locations
Balchem has offices in New Hampton, Atlanta, Chicago, Covington and in 6 other locations
New Hampton, US (HQ)
52 Sunrise Park Rd
Atlanta, US
Atlanta, GA, USA
Chicago, US
Chicago, IL, USA
Covington, US
Covington, LA, USA
Lincoln, US
Lincoln, NE, USA
Los Angeles, US
Los Angeles, CA, USA
Balchem Financials and Metrics
Balchem Revenue
Balchem's revenue was reported to be $643.71 m in FY, 2019
| USD | |
|---|---|
Revenue (Q2, 2020) | 173.4m |
Gross profit (Q2, 2020) | 55.4m |
Gross profit margin (Q2, 2020), % | 31.9% |
Net income (Q2, 2020) | 21.1m |
EBIT (Q2, 2020) | 26.9m |
Market capitalization (15-Oct-2020) | 3.4b |
Closing stock price (15-Oct-2020) | 104.4 |
Cash (30-Jun-2020) | 76.4m |
EV | 3.5b |
Balchem's current market capitalization is $3.4 b.
- Source: SEC Filings
Annual
Quarterly
| USD | Q2, 2011 | Q3, 2011 | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 74.7m | 74.4m | 76.2m | 79.0m | 75.1m | 84.7m | 83.3m | 87.6m | 86.0m | 132.2m | 160.5m | 144.9m | 134.8m | 140.1m | 135.1m | 138.8m | 138.5m | 137.7m | 147.1m | 150.7m | 161.4m | 163.7m | 155.0m | 157.0m | 161.6m | 158.6m | 174.4m | 173.4m |
Cost of goods sold | 52.9m | 51.8m | 55.0m | 56.4m | 51.7m | 60.4m | 58.4m | 63.1m | 62.8m | 99.9m | 116.0m | 101.7m | 92.9m | 97.0m | 92.3m | 92.3m | 93.9m | 93.3m | 100.3m | 104.5m | 110.0m | 110.2m | 107.0m | 107.9m | 107.6m | 104.6m | 119.1m | 118.0m |
Gross profit | 21.8m | 22.6m | 21.2m | 22.6m | 23.4m | 24.2m | 24.9m | 24.5m | 23.2m | 32.3m | 44.5m | 43.1m | 41.9m | 43.2m | 42.8m | 46.4m | 44.7m | 44.4m | 46.8m | 46.2m | 51.5m | 53.5m | 48.0m | 49.1m | 53.9m | 54.0m | 55.3m | 55.4m |
Gross profit Margin, % | 29% | 30% | 28% | 29% | 31% | 29% | 30% | 28% | 27% | 24% | 28% | 30% | 31% | 31% | 32% | 33% | 32% | 32% | 32% | 31% | 32% | 33% | 31% | 31% | 33% | 34% | 32% | 32% |
- Source: SEC Filings
Annual
Quarterly
| USD | Q2, 2011 | Q3, 2011 | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 89.7m | 104.9m | 121.3m | 138.1m | 147.2m | 149.1m | 171.2m | 190.2m | 207.3m | 59.7m | 25.4m | 56.6m | 72.2m | 81.6m | 39.2m | 33.4m | 32.5m | 37.0m | 43.6m | 34.7m | 42.7m | 62.5m | 42.7m | 39.0m | 41.7m | 59.4m | 74.0m | 76.4m |
Accounts Receivable | 38.5m | 36.4m | 38.0m | 36.8m | 36.9m | 45.7m | 39.7m | 40.5m | 43.8m | 74.5m | 72.6m | 64.1m | 63.5m | 64.2m | 69.4m | 67.1m | 68.8m | 79.2m | 84.8m | 86.7m | 96.0m | 98.6m | 101.2m | 99.8m | 101.6m | 94.0m | 105.9m | 97.1m |
Prepaid Expenses | 1.8m | 1.6m | 2.2m | 2.0m | 1.9m | 2.2m | 2.0m | 1.6m | 2.1m | 3.9m | 2.5m | 3.4m | 3.2m | 2.5m | 3.0m | 4.2m | 2.8m | 3.3m | 5.0m | 3.2m | 4.0m | 4.9m | 3.8m | 3.5m | 5.3m | 4.1m | 4.1m | 5.9m |
Inventories | 18.9m | 18.4m | 20.1m | 20.1m | 20.3m | 23.8m | 24.7m | 24.7m | 24.9m | 57.0m | 58.2m | 50.5m | 47.9m | 50.7m | 60.4m | 57.8m | 56.7m | 62.9m | 62.1m | 59.6m | 66.3m | 70.1m | 71.8m | 66.8m | 68.4m | 73.8m | 83.2m | 81.5m |
- Source: SEC Filings
Annual
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
|---|---|---|---|---|---|---|---|---|---|
Net Income | 38.8m | 40.0m | 44.9m | 52.8m | 59.7m | 56.0m | 90.1m | 78.6m | 79.7m |
Depreciation and Amortization | 9.3m | 9.6m | 10.5m | 30.5m | 40.0m | 46.2m | 44.4m | 44.7m | 45.9m |
Inventories | (3.0m) | (2.0m) | (3.9m) | 6.7m | 3.1m | 4.7m | (319.0k) | (6.0m) | (11.4m) |
Accounts Payable | 739.0k | 5.8m | (2.8m) | 7.7m | (15.7m) | 17.8m | 1.5m | 6.0m | 1.1m |
Quarterly
| USD | Q2, 2011 | Q3, 2011 | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 18.5m | 29.3m | 9.3m | 19.2m | 30.1m | 10.9m | 22.5m | 34.1m | 8.9m | 18.6m | 33.8m | 15.2m | 30.1m | 44.1m | 11.9m | 26.0m | 40.0m | 15.5m | 32.1m | 48.1m | 19.3m | 39.0m | 58.2m | 18.8m | 38.6m | 59.3m | 19.8m | 40.9m |
Depreciation and Amortization | 4.5m | 6.9m | 2.4m | 4.8m | 7.2m | 2.6m | 5.2m | 7.8m | 2.6m | 9.9m | 20.2m | 10.0m | 19.9m | 29.8m | 11.0m | 22.7m | 34.4m | 11.3m | 22.1m | 33.2m | 11.1m | 22.4m | 33.5m | 10.8m | 21.7m | 33.5m | 12.5m | 25.3m |
Inventories | (3.0m) | (2.7m) | (1.3m) | (1.5m) | (1.7m) | (3.3m) | (4.1m) | (4.0m) | (50.0k) | (256.0k) | (1.7m) | (1.3m) | 1.4m | (1.4m) | 1.3m | 4.0m | 5.5m | (5.6m) | (2.0m) | 682.0k | (5.4m) | (9.6m) | (10.5m) | (139.0k) | (681.0k) | (6.0m) | 528.0k | 2.3m |
Accounts Payable | 641.0k | (800.0k) | (362.0k) | 2.6m | 2.1m | (3.7m) | (5.1m) | (5.3m) | 400.0k | 3.3m | 3.7m | (7.0m) | (9.8m) | (6.6m) | 7.1m | 3.6m | 2.4m | (9.1m) | (7.6m) | (3.5m) | (2.3m) | 754.0k | 5.4m | (12.4m) | (11.0m) | (145.0k) | (3.1m) | (9.2m) |
- Source: SEC Filings
| USD | Q2, 2011 |
|---|---|
Financial Leverage | 1.2 x |
Balchem Operating Metrics
Balchem's Backlog was reported to be 26.2m in FY, 2016.
| FY, 2015 | FY, 2016 | |
|---|---|---|
Backlog | 30.45 m | 26.20 m |
Facilities | 19 | |
Patents Issued | 109 |
Balchem Cybersecurity Score
Balchem Revenue Breakdown
Balchem revenue breakdown by business segment: 53.7% from Human Nutrition & Health, 29.1% from Animal Nutrition & Health, 12.7% from Specialty Products and 4.5% from Other
Balchem Online and Social Media Presence
127 Twitter followers
Balchem has 127 Twitter Followers. The number of followers has increased 1% month over month and increased 2.2% quarter over quarter
Balchem's Trends
Balchem News and Updates
October 14, 2020
Balchem Corporation Announces Quarterly Conference Call for Third Quarter Financial Results on October 28, 2020
NEW HAMPTON, N.Y., Oct. 14, 2020 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Wednesday, October 28, 2020 at 11:00 AM Eastern Time (ET) to review third quarter results. Ted Harris, Chairman of the Board, CEO and President and Martin …
September 23, 2020
Balchem Corporation to Present at Morningstar's Management Behind the Moat Conference September 29, 2020
NEW HAMPTON, N.Y., Sept. 23, 2020 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) Chairman of the Board, Chief Executive Officer, and President Ted Harris and Chief Financial Officer Martin Bengtsson will present at Morningstar's Management Behind the Moat Conference on Tuesday, September 2…
September 15, 2020
Balchem Corporation to Present at the Sidoti Fall 2020 Virtual Investor Conference on September 23, 2020
NEW HAMPTON, N.Y., Sept. 15, 2020 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) Chairman of the Board, Chief Executive Officer, and President Ted Harris and Chief Financial Officer Martin Bengtsson will present at the Sidoti Fall 2020 Virtual Investor Conference on Wednesday, September 23…
July 31, 2020
Balchem Corporation Reports Record Second Quarter Sales of $173.4 Million, Net Earnings of $21.1 Million, GAAP EPS of $0.65, and Adjusted EPS of $0.85
NEW HAMPTON, N.Y., July 31, 2020 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today record second quarter net earnings of $21.1 million for 2020, compared to net earnings of $19.8 million for the second quarter 2019. Record second quarter adjusted net earnings(a) were $27.6 mil…
April 17, 2020
Balchem Corporation Announces Quarterly Conference Call for First Quarter Financial Results on May 1, 2020
NEW HAMPTON, N.Y., April 17, 2020 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, May 1, 2020 at 11:00 AM Eastern Time (ET) to review first quarter results. Ted Harris, Chairman of the Board, CEO and President and Martin Bengts…
February 21, 2020
Balchem Corporation Reports Record Fourth Quarter Sales of $166.5 Million, GAAP EPS of $0.63 and Adjusted EPS of $0.88
NEW HAMPTON, N.Y., Feb. 21, 2020 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today reported for the fourth quarter 2019 net earnings of $20.4 million, compared to net earnings of $20.3 million for the fourth quarter 2018. Fourth quarter adjusted net earnings(a) were $28.4 million, compa…
Balchem Blogs
June 04, 2020
National Cheese Day
Today is National Cheese Day! We are so excited to celebrate this by sharing Balchem's cheese-related applications.
May 26, 2020
Devil’s Food Cake Recipe
We have a delectable Devil's Food Cake Recipe to share with you. This recipe includes our BakeShure® Encapsulates to boost quality and consistency through pH optimization, flavor delivery, leavening control, moisture control, and antimicrobial preservation.
May 11, 2020
2021 Frozen Dessert Feature Flavors
This week's blog post is a spotlight on our 2021 Frozen Dessert Feature Flavors. These flavors are full of exciting colors, delicious textures and innovative ice cream technology from Balchem.
May 06, 2020
On May 14th, 2020, Balchem Corporation Presented at the BMO 15th Annual Farm to Market Conference
Ted Harris, Balchem’s Chairman and CEO, and Martin Bengtsson, Balchem’s CFO, presented at the BMO 15th Annual Global Farm to Market Conference on Thursday, May 14, 2020. The presentation is available to download below. A recording of the webcast is also available. Click here to access the webcast.
April 30, 2020
Think Spring with Balchem 2021 Inclusions Feature Flavors
The indulgent delicacy of fresh baked cookies and cakes are enhanced with Balchem’s Spring 2021 Feature Flavors Inclusions launch.
Balchem Frequently Asked Questions
When was Balchem founded?
Balchem was founded in 1967.
Who are Balchem key executives?
Balchem's key executives are Ted Harris, Martin Bengtsson and Mark Stach.
How many employees does Balchem have?
Balchem has 1,424 employees.
What is Balchem revenue?
Latest Balchem annual revenue is $643.7 m.
What is Balchem revenue per employee?
Latest Balchem revenue per employee is $452 k.
Who are Balchem competitors?
Competitors of Balchem include Kemin Industries, Huami and Daring Foods.
Where is Balchem headquarters?
Balchem headquarters is located at 52 Sunrise Park Rd, New Hampton.
Where are Balchem offices?
Balchem has offices in New Hampton, Atlanta, Chicago, Covington and in 6 other locations.
How many offices does Balchem have?
Balchem has 10 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies